Biocon biologics receives European Commission approval for Vevzuo, Evfraxy Denosumab biosimilars for bone diseases
on Thursday said its arm
Biocon Biologics
Ltd has been granted marketing authorisation by the European Commission for
Vevzuo
and
Evfraxy
biosimilars of Denosumab used in the treatment of different bone diseases.
The marketing authorisation for the European Union (EU) follows a positive opinion issued by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) on April 25, 2025, Biocon Ltd said in a regulatory filing.
Vevzuo is authorised for the prevention of bone complications in adults with advanced cancer involving bone and the treatment of adults and skeletally mature adolescents with giant cell tumour (GCT) of bone.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Join new Free to Play WWII MMO War Thunder
War Thunder
Play Now
Evfraxy is authorised for the treatment of osteoporosis in men and postmenopausal women, the treatment of bone loss linked to hormone ablation in men with prostate cancer at increased risk of fractures or the treatment of bone loss associated with long-term systemic glucocorticoid therapy in adults, the company said.
"The approval of Vevzuo and Evfraxy in Europe underscores our strong scientific expertise and commitment to expanding patient access to essential medicines, including to new therapeutic areas such as bone health," Biocon Biologics CEO & Managing Director Shreehas Tambe said.
Live Events
Further, Tambe said, "In the past 18 months, we have successfully secured
regulatory approvals
for three biosimilars in Europe and two in the UK. These
Denosumab biosimilars
mark another significant milestone in our rapid expansion and support for healthcare systems in the region."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
43 minutes ago
- Time of India
India proposes retaliatory duties against US auto tariffs
NEW DELHI: India on Friday proposed imposing of retaliatory duties under WTO norms against the US tariffs on imports of auto parts in the name of safeguard measures. "The proposed suspension of concessions or other obligations would take the form of an increase in tariffs on selected products originating in the US," according to a notification of the WTO being circulated at the request of India. India has notified WTO's Council for Trade in Goods of its proposed suspension of concessions and other obligations under certain WTO provisions. "This notification is made in connection with safeguard measures extended by the United States of America on imports of automobile parts from India," it said. On March 26 this year, the US adopted a safeguard measure in the form of a tariff increase of 25% ad valorem on imports of passenger vehicles and light trucks, and on certain auto parts from India. These measures apply from May 3, 2025 as regards auto parts, and for an unlimited duration. The measures have not been notified by the US to the WTO, but are, in essence, safeguard measures. India has maintained that the measures taken by the US are not consistent with the GATT (General Agreement on Trade and Tariff) 1994 and the agreement on safeguards. As consultations sought by India on these tariffs have not taken place, "India reserves the right to suspend concessions or other obligations", the WTO notification added. Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like They Were So Beautiful Before; Now Look At Them; Number 10 Will Shock You Reportingly Undo by Taboola by Taboola The safeguard measures would affect $2,895 million imports annually into the US of the relevant products originating in India, on which the duty collection would be $723.8 million. "Accordingly, India's proposed suspension of concessions would result in an equivalent amount of duty collected from products originating in the US," it said. To ensure the effective exercise of its right to suspend substantially equivalent concessions or other obligations, the multinational body said, India has reserved its right to adjust the products as well as the tariff rates. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
43 minutes ago
- Time of India
5 districts corner 5L cr realty boom
Ahmedabad: Gujarat's real estate sector attracted Rs 5.03 lakh crore in investments since the implementation of the Real Estate (Regulation and Development) Act (RERA) in 2017. However, a lion's share of 94% of this capital is concentrated in just five districts: Ahmedabad, Gandhinagar, Surat, Vadodara and Rajkot, largely driven by rapid urbanisation, better infrastructure, and stronger demand for housing and commercial spaces. In contrast, the remaining 28 districts, which house nearly two-thirds (64%) of Gujarat's population, received only 6% of the total investment. Experts, however, have raised concerns over resource concentration and highlighted the need for more equitable infrastructure growth across Gujarat's smaller towns. According to the latest data released by the Gujarat Real Estate Regulatory Authority (GujRERA), these five urban hubs account for 86% of all registered projects and 89% of the total housing units in the state. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad Ahmedabad alone attracted Rs 2.1 lakh crore, or 42% of the total investment, solidifying its position as the state's real estate capital. It also accounted for 31% of registered projects and 35% of all housing units. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch CFD với công nghệ và tốc độ tốt hơn IC Markets Đăng ký Undo "Ahmedabad has emerged as one of the fastest-growing cities in India due to rapid infrastructure development and job creation," said Dipak Patel, president of CREDAI Gujarat. "Higher education levels and urban migration are also driving real estate growth in large cities. In smaller towns, plotting schemes are more popular, where individuals build their own homes, and these often don't reflect in RERA data. Also, many small projects in small towns do not get registered with RERA so their actual share may be a bit higher. " However, the skewed development of the state limited to urban centres is fairly visible. Drawing on the 2011 Census data, only 36% of Gujarat's population lives in its top five districts, which account for an overwhelming majority of the state's real estate activity. The remaining 64%, spread across smaller towns and rural regions, has seen just a fraction of the investment and project activity. "All other districts collectively account for 16% of project contribution, 6% of investments, and 11% of units, suggesting a dispersed yet modest contribution from remaining regions," the report states, hinting at a widening regional divide in infrastructure development and economic and commercial activities. Since RERA's implementation, Gujarat saw the registration of 15,260 projects covering a carpet area of 13.11 crore sq m, translating into 18.20 lakh housing units. Of these, over 8,400 projects were completed.
Time of India
44 minutes ago
- Time of India
Gujarat hospitals see worrying resistance to powerful antibiotics
SLUG: STATE's AMR PROFILE Ahmedabad: A recent govt study has revealed a worrying trend in Gujarat's hospitals — some of the most powerful antibiotics are no longer effective against common bacterial infections. The report found that more than 40% of E. coli and Klebsiella bacteria — two major antimicrobial-resistant (AMR) pathogens often responsible for serious infections — are now resistant to carbapenems, a high-end antibiotic typically used when all others fail. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad This is one of the key findings of the surveillance report by the Gujarat State Antimicrobial Resistance Surveillance Network (GUJSAR), released on Wednesday. The report analysed 14,685 AMR isolates collected between July 1 and December 31, 2024, from 22 network laboratories, including microbiology labs of six govt medical colleges, 13 GMERS medical colleges, and three municipal corporation-run medical colleges. "While other drugs are still available — including colistin, the last resort for very severe bacterial infections — resistance to carbapenems signals that we are rapidly running out of feasible antibiotic options for serious infections. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 今すぐ、2025年最高のRPGゲームを制覇しよう！ BuzzDaily Winners ゲームをプレイ Undo Switching to a higher class of antibiotics also brings short-term and long-term side effects," said a senior city-based microbiologist. A senior state health department official told TOI that Gujarat is among the few Indian states with a dedicated AMR surveillance network. "All steps — from identifying antimicrobial resistance to specific antibiotics to reporting isolates — are standardized," the official said. T he report focuses on priority pathogens, identified by the World Health Organization (WHO) as posing the highest threat to human health due to their resistance to existing antibiotics. The findings show that the majority of AMR isolates were from urine samples (42%), followed by pus aspirates (31%). About 62% of the isolates came from hospitalized patients, and 16% from patients in intensive care units (ICUs). Sources said that AMR organisms have been rising steadily — a trend also highlighted in Indian Council of Medical Research (ICMR) reports. "In recent years, gram-negative bacteria have shown increased resistance to several commonly used antibiotics. Some bacteria isolated from blood cultures also showed resistance, suggesting that if the correct antibiotics are not administered in time, it can lead to septicaemia — a potentially life-threatening bloodstream infection," said a microbiologist.
